Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 13 most recent Form 4 transactions.
| Jan 2 |
| PHAT |
| Phathom Pharmaceuticals,… |
| AGRANT◆ |
| 226,156 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| Jan 2 | PHAT | Phathom Pharmaceuticals,… | AGRANT | 251,034 | — | — | +220.6% | Open the original filing on SEC.gov |
| Dec 17, 2025 | PHAT | Phathom Pharmaceuticals,… | FTAX | 31,502 | $15.36 | $483.9K | -21.7% | Open the original filing on SEC.gov |
| Dec 17, 2025 | PHAT | Phathom Pharmaceuticals,… | AGRANT | 62,038 | — | — | +74.5% | Open the original filing on SEC.gov |
| Dec 12, 2025 | VYNE | VYNE Therapeutics Inc. | AGRANT◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 28, 2025 | PHAT | Phathom Pharmaceuticals,… | MEXER◆ | 90,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 28, 2025 | PHAT | Phathom Pharmaceuticals,… | FTAX | 48,375 | $15.62 | $755.6K | -36.8% | Open the original filing on SEC.gov |
| Nov 28, 2025 | PHAT | Phathom Pharmaceuticals,… | MEXER | 90,000 | — | — | +216.2% | Open the original filing on SEC.gov |
| Sep 25, 2025 | PHAT | Phathom Pharmaceuticals,… | MEXER◆ | 90,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 25, 2025 | PHAT | Phathom Pharmaceuticals,… | FTAX | 48,375 | $11.66 | $564.1K | -53.8% | Open the original filing on SEC.gov |
| Sep 25, 2025 | PHAT | Phathom Pharmaceuticals,… | MEXER | 90,000 | — | — | — | Open the original filing on SEC.gov |